î•ñŒ¹ „ ‘Ђ̖|–ómDnbó‘B‚Ì”Y‚Ý‚É“š‚¦‚é–{‘æ4•”E‘æ20Í
ŽQl•¶Œ£
1. T. Zheng, T. R. Holford, Y. Chen, et al., Time Trend and Age-Period-Cohort Effect on Incidence of Thyroid Cancer in Connecticut, 1935-1992, International Journal of Cancer 67 (1996): 504-9.
2. B. L. Solomon, L. Wartofsky, and K. D. Burman, Current Trends in the Management of Well-Differentiated Papillary Thyroid Carcinoma, Journal of Clinical Endocrinology and Metabolism 81 (1996): 333-39.
3. R. L. Rossi, B. Cady, and M. L. Silverman, Surgically Incurable Well-Differentiated Thyroid Carcinoma: Prognostic Factors and Results of Therapy, Archives of Surgery 123 (1988): 569-74.
4. D. Zimmerman, I. D. Hay, and I. R. Gough, Papillary Thyroid Carcinoma in Children and Adults: Long-Term Follow-up of I039 Patients Conservatively Treated at One Institution during Three Decades, Surgery 104 (1988): 1157-66.
5. A. Schindler, G. Van Melle, B. Evequoz, et al., Prognostic Factors in Papillary Carcinoma of the Thyroid, Cancer 68 (1991): 324-30.
6. D. P. Aiello and A. Manni, Thyroglobulin Measurements vs. Iodine 131-I Total-Body Scan for Follow-up of Well-Differehtiated Thyroid Cancer, Archives of Internal Medicine 150 (1990): 437-39.
7. A. Brander, P. Viikinkoski, J. Nickels, et al., Thyroid Gland: U.S. Screening in a Random Adult Population, Radiology 181 (1991): 683-87.
8. F. S. Greenspan, The Role of Fine-Needle Aspiration Biopsy in the Management of Palpable Thyroid Nodules, Pathology Patterns 108, no. 4, suppl. (1997): S26-S30.
9. M. Boignon and D. Moyer, Solitary Thyroid Nodules: Separating Benign from Malignant Conditions, Postgraduate Medicine 98, no. 2 (1995): 73-80.
10. R. M. Tuttle, H. Lemar, and H. B. Burch, Clinical Features Associated with an Increased Risk of Thyroid Malignancy in Patients with Follicular Neoplasia by FineNeedle Aspiration, Thyroid 8, no. 5 (1998): 377-83.
11. E. Papini, L. Petrucci, R. Guglielmi, et al., Long-Term Changes in Nodular Goiter: A 5-Year Prospective Randomized Trial of Levothyroxine Suppressive Therapy for Benign Cold Thyroid Nodules, Journal of Clinical Endocrinology and Metabolism 83 (1998): 780-83.
12. A. E. Schwartz, O. H. Clark, P. Ituarte, et al., Therapeutic Controversy: Thyroid Surgery-The Choice, Journal of Clinical Endocrinology and Metabolism 83 , no. 4 (1998): 1097-1105.
13. L. A. Burmeister, R. P. du Cret, and C. N. Mariash, Local Reactions to Radioiodine in the Treatment of Thyroid Cancer, American Journal of Medicine 90 (1991): 217-22.
14. P. W. Ladenson, L. E. Braverman, E. L. Mazzaferri, et al., Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive lodine Scanning in Patients with Thyroid Carcinoma, New England Journal of Medicine 337, no. 13 (1997): 888-96.
15. J. D. Pineda, T. Lee, K. Ain, et al., lodine-131 Therapy for Thyroid Cancer Patients with Elevated Thyroglobulin and Negative Diagnostic Scan, Journ:al of Clinical Endocrinology and Metabolism 80 (1995): 1488-92.
16. P. Hall, L. E. Holm, G. Lundell, et al., Cancer Risks in Thyroid Cancer Patients, British Journal of Cancer 64 (1991): 159-63.
m‚à‚Ç‚én